Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Wound Care Dressings), By Type (Neuro-Ischemic, Neuropathic), By End-use, By Country, And Segment Forecasts, 2025

The Europe diabetic foot ulcer treatment market size is expected to reach USD 2.32 billion by 2030, registering a CAGR of 5.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years. Many adjuvant therapies, such as nonsurgical debridement agents, dressings & topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies, are said to effectively improve and cure DFU.

Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme, allows the body to heal the wound at a quicker rate. The biologics segment held the largest revenue share in 2021 and is projected to expand further at the fastest CAGR during the forecast period. Biologics include growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF), stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation & circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share, followed by therapy devices and antibiotic medications, in 2021. Industry players are constantly developing new and improved products to ensure quicker healing time for DFU.

Europe Diabetic Foot Ulcer Treatment Market Report Highlights:

The neuro-ischemic ulcers segment held the largest market share of 53.10% in 2023 and is expected to continue its dominance over the forecast period.
The biologics segment dominated the market, with a 36.37% share in 2024, owing to the high demand for biologicals in the treatment of diabetic foot.
The homecare segment accounted for a share of 52.72% in 2024 and is expected to grow fastest during the forecast period. The growth of the segment can be attributed to several key factors.
The diabetic foot ulcer treatment market in Germany is expected to grow owing to the increasing recurrence of foot ulcers in diabetic patients in Germany.

Product Code: GVR-4-68039-959-6

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Treatment
- 1.2.2. Ulcer Type
- 1.2.3. Application
- 1.2.4. End Use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Treatment outlook
- 2.2.2. Type outlook
- 2.2.3. Application outlook
- 2.2.4. End use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Europe Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing prevalence of neurological diseases
  - 3.2.1.2. Growing R&D activities,
  - 3.2.1.3. Technological advancements
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Lack of skilled professionals
3.3. Europe Diabetic Foot Ulcer Treatment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Europe Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Europe Diabetic Foot Ulcer Treatment Market Movement Analysis
4.3. Global Europe Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Wound care dressings
- 4.5.1. Wound care dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.2. Alginate dressings
  - 4.5.2.1. Alginate dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.3. Hydrofiber dressings
  - 4.5.3.1. Hydrofiber dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.4. Foam dressings
  - 4.5.4.1. Foam dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.5. Film dressings
  - 4.5.5.1. Film dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.6. Hydrocolloid dressings
  - 4.5.6.1. Hydrocolloid dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.7. Surgical dressings
  - 4.5.7.1. Surgical dressings market estimates and forecasts 2018 - 2030 (USD Million)
- 4.5.8. Hydrogel dressings
  - 4.5.8.1. Hydrogel dressings market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Biologics
- 4.6.1. Biologics market estimates and forecasts 2018 - 2030 (USD Million)
- 4.6.2. Growth factors
  - 4.6.2.1 Growth factors market estimates and forecasts 2018 - 2030 (USD Million)
- 4.6.3. Skin grafts
  - 4.6.3.1 Skin grafts market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Therapy devices
- 4.7.1. Therapy devices market estimates and forecasts 2018 - 2030 (USD Million)
- 4.7.2. Negative pressure wound therapy
  - 4.7.2.1. Negative pressure wound therapy market estimates and forecasts 2018 - 2030 (USD Million)
- 4.7.3. Ultrasound therapy
  - 4.7.3.1. Ultrasound therapy market estimates and forecasts 2018 - 2030 (USD Million)
4.8. Antibiotics
- 4.8.1. Antibiotics market estimates and forecasts 2018 - 2030 (USD Million)
4.9. Others
- 4.9.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Europe Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Europe Diabetic Foot Ulcer Treatment Ulcer Type Market Movement Analysis
5.3. Europe Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Ulcer Type, 2018 to 2030 (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Neuropathic ulcers
- 5.5.1. Neuropathic ulcers market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Ischemic ulcers
- 5.6.1. Ischemic ulcers market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Neuro-ischemic ulcers
- 5.7.1. Neuro-ischemic ulcers market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Europe Diabetic Foot Ulcer Treatment Market: End-use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Europe Diabetic Foot Ulcer Treatment Application Market Movement Analysis
6.3. Europe Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals and clinics
- 6.5.1. Hospitals and clinics market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Ambulatory surgical centers
- 6.6.1. Ambulatory surgical centers market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Homecare (Others)
- 6.7.1. Homecare (Others) market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Europe Diabetic Foot Ulcer Treatment Market: Country Estimates & Trend Analysis By Treatment, Type, Application, End Use

7.1. Country Market Share Analysis, 2023 & 2030
7.2. Country Market Dashboard
7.3. Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. Europe
- 7.5.1. Regulatory framework/ reimbursement structure
- 7.5.2. UK
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework/ reimbursement structure
  - 7.5.2.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework/ reimbursement structure
  - 7.5.3.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Competitive scenario
  - 7.5.4.3. Regulatory framework/ reimbursement structure
  - 7.5.4.4. France market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Competitive scenario
  - 7.5.5.3. Regulatory framework/ reimbursement structure
  - 7.5.5.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Competitive scenario
  - 7.5.6.3. Regulatory framework/ reimbursement structure
  - 7.5.6.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.7. Norway
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Competitive scenario
  - 7.5.7.3. Regulatory framework/ reimbursement structure
  - 7.5.7.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Competitive scenario
  - 7.5.8.3. Regulatory framework/ reimbursement structure
  - 7.5.8.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
- 7.5.9. Denmark
  - 7.5.9.1. Key country dynamics
  - 7.5.9.2. Competitive scenario
  - 7.5.9.3. Regulatory framework/ reimbursement structure
  - 7.5.9.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2023
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
- 8.6.1. ConvaTec Group PLC
  - 8.6.1.1. Company overview
  - 8.6.1.2. Financial performance
  - 8.6.1.3. Product benchmarking
  - 8.6.1.4. Strategic initiatives
- 8.6.2. Acelity L.P. Inc.
  - 8.6.2.1. Company overview
  - 8.6.2.2. Financial performance
  - 8.6.2.3. Product benchmarking
  - 8.6.2.4. Strategic initiatives
- 8.6.3. 3M Health Care
  - 8.6.3.1. Company overview
  - 8.6.3.2. Financial performance
  - 8.6.3.3. Product benchmarking
  - 8.6.3.4. Strategic initiatives
- 8.6.4. Coloplast Corp.
  - 8.6.4.1. Company overview
  - 8.6.4.2. Financial performance
  - 8.6.4.3. Product benchmarking
  - 8.6.4.4. Strategic initiatives
- 8.6.5. Smith & Nephew Plc.
  - 8.6.5.1. Company overview
  - 8.6.5.2. Financial performance
  - 8.6.5.3. Product benchmarking
  - 8.6.5.4. Strategic initiatives
- 8.6.6. B. Braun SE
  - 8.6.6.1. Company overview
  - 8.6.6.2. Financial performance
  - 8.6.6.3. Product benchmarking
  - 8.6.6.4. Strategic initiatives
- 8.6.7. Medline Industries, LP
  - 8.6.7.1. Company overview
  - 8.6.7.2. Financial performance
  - 8.6.7.3. Product benchmarking
  - 8.6.7.4. Strategic initiatives
- 8.6.8. Organogenesis, Inc.
  - 8.6.8.1. Company overview
  - 8.6.8.2. Financial performance
  - 8.6.8.3. Product benchmarking
  - 8.6.8.4. Strategic initiatives
- 8.6.9. Molnlycke Health Care AB
  - 8.6.9.1. Company overview
  - 8.6.9.2. Financial performance
  - 8.6.9.3. Product benchmarking
  - 8.6.9.4. Strategic initiatives
- 8.6.10. Medtronic.
  - 8.6.10.1. Company overview
  - 8.6.10.2. Financial performance
  - 8.6.10.3. Product benchmarking
  - 8.6.10.4. Strategic initiatives

Product Code: GVR-4-68039-959-6

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Europe diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 4 Europe diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 5 Europe diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 6 Europe diabetic foot ulcer treatment market by Country, 2018 - 2030 (USD Million)
Table 7 UK diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 8 UK diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 9 UK diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 10 Germany diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 11 Germany diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 12 Germany diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 13 France diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 14 France diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 15 France diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 16 Italy diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 17 Italy diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 18 Italy diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 19 Spain diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 20 Spain diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 21 Spain diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 22 Denmark diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 23 Denmark diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 24 Denmark diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 25 Sweden diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 26 Sweden diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 27 Sweden diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 28 Norway diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
Table 29 Norway diabetic foot ulcer treatment market by type, 2018 - 2030 (USD Million)
Table 30 Norway diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
Table 31 Participant's overview
Table 32 Financial performance
Table 33 Key companies undergoing expansions
Table 34 Key companies undergoing acquisitions
Table 35 Key companies undergoing collaborations
Table 36 Key companies launching new products/services
Table 37 Key companies undergoing partnerships
Table 38 Key companies undertaking other strategies

List of Figures

Fig. 1. Market research process
Fig. 2. Data triangulation techniques
Fig. 3. Primary research pattern
Fig. 4. Market research approaches
Fig. 5. Market formulation & validation
Fig. 6. Market summary, 2023 (USD Million)
Fig. 7. Market segmentation & scope
Fig. 8. Market driver impact
Fig. 9. Market restraint impact
Fig. 10. Porter's analysis
Fig. 11. SWOT analysis
Fig. 12. Europe diabetic foot ulcer treatment market: Treatment outlook and key takeaways
Fig. 13. Europe diabetic foot ulcer treatment market: Treatment movement analysis
Fig. 14. Wound care dressings market, 2018 - 2030 (USD Million)
Fig. 15. Biologics market, 2018 - 2030 (USD Million)
Fig. 16. Therapy devices market, 2018 - 2030 (USD Million)
Fig. 17. Antibiotic medications market, 2018 - 2030 (USD Million)
Fig. 18. Others, 2018 - 2030 (USD Million)
Fig. 19. Europe diabetic foot ulcer treatment market: Type outlook and key takeaways
Fig. 20. Europe diabetic foot ulcer treatment market: Type movement analysis
Fig. 21. Neuropathic ulcers market, 2018 - 2030 (USD Million)
Fig. 22. Ischemic ulcers market, 2018 - 2030 (USD Million)
Fig. 23. Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
Fig. 24. Europe diabetic foot ulcer treatment market: End use outlook and key takeaways
Fig. 25. Europe Diabetic foot ulcer treatment market: End use movement analysis
Fig. 26. Hospital and clinics market, 2018 - 2030 (USD Million)
Fig. 27. Ambulatory surgical services market, 2018 - 2030 (USD Million)
Fig. 28. Homecare (Others) market, 2018 - 2030 (USD Million)
Fig. 29. Europe
Fig. 30. Europe market estimates and forecasts, 2018 - 2030
Fig. 31. UK
Fig. 32. UK market estimates and forecasts, 2018 - 2030
Fig. 33. Germany
Fig. 34. Germany market estimates and forecasts, 2018 - 2030
Fig. 35. France
Fig. 36. France market estimates and forecasts, 2018 - 2030
Fig. 37. Italy
Fig. 38. Italy market estimates and forecasts, 2018 - 2030
Fig. 39. Spain
Fig. 40. Spain market estimates and forecasts, 2018 - 2030
Fig. 41. Denmark
Fig. 42. Denmark market estimates and forecasts, 2018 - 2030
Fig. 43. Sweden
Fig. 44. Sweden market estimates and forecasts, 2018 - 2030
Fig. 45. Norway
Fig. 46. Norway market estimates and forecasts, 2018 - 2030
Fig. 47. Heat map analysis
Fig. 48. Market participant categorization
Fig. 49. Europe Diabetic foot ulcer treatment market share analysis, 2023
Fig. 50. Strategy framework

Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Wound Care Dressings), By Type (Neuro-Ischemic, Neuropathic), By End-use, By Country, And Segment Forecasts, 2025 - 2030

Description

Table of Contents

List of Tables

Europe Diabetic Foot Ulcer Treatment Market Growth & Trends:

Europe Diabetic Foot Ulcer Treatment Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Europe Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope

Chapter 4. Europe Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis

Chapter 5. Europe Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis

Chapter 6. Europe Diabetic Foot Ulcer Treatment Market: End-use Estimates & Trend Analysis

Chapter 7. Europe Diabetic Foot Ulcer Treatment Market: Country Estimates & Trend Analysis By Treatment, Type, Application, End Use

Chapter 8. Competitive Landscape

List of Tables

List of Figures